News
The Business Matrix: Tuesday 31 July 2012
www.independent.co.uk
[The Independent] - Cillit Bang, Nurofen and Durex are selling well for Reckitt Benckiser. Reckitt managed to avoid the profit warnings issued by its rival Procter & Gamble as investing in its biggest brands helped overcome economic troubles in Europe. Half-year profits
Google News: London open: Central bank hopes drive gains early on
[ShareCast] - Cillit Bang maker Reckitt Benckiser fell after reported revenues fell 1% in the second quarter. Nevertheless, net revenue in the first half of the year was £4669m, up 1% year-on-year using actual exchange rates and up 4% on a constant exchange rates
REFILE-UPDATE 2-Reckitt sees slow growth as southern Europe drags
in.reuters.com
[Reuters] - Reckitt, which also makes Nurofen, Cillit Bang and Air Wick, said half-year adjusted earnings rose 2 percent to pence a share, beating a company-compiled forecast of 110 pence. It is paying a half-year dividend of 56 pence a share, up 2 percent.
Guardian: Reckitt Benckiser slips despite Cillit Bang maker's profits edging higher
[The Guardian (blog)] - Reckitt Benckiser is the biggest faller in a rising FTSE 100 after the Cillit Bang maker despite outperforming some of its consumer goods peers. The company unveiled a 2% rise in half year operating profits to £1.12bn, compared to a recent warning from
sorted by relevance / date